The settlement will benefit individuals who paid for cancer medications Thalomid or Revlimid in any eligible districts or states any time before May 20, 2020. You may be eligible for a potential award from the Cancer Medications Thalomid & Revlimid Class Action Lawsuit!
According to the class action, the drug maker conspired to keep cheaper, generic versions of these cancer drugs from entering the market in an effort to generate more profit from their name-brand drugs. So if you are eligible, file a claim by October 15, 2020 to receive your potential award!
Cancer Medications Thalomid & Revlimid Class Action Lawsuit
- Claim Form Deadline: October 15, 2020
- Who’s Eligible: Class Members include all of those patients or third-party payors who paid for Thalomid or Revlimid in California, the District of Columbia, Florida, Kansas, Maine, Massachusetts, Michigan, Nebraska, New York, North Carolina, Oregon, Pennsylvania, Rhode Island, or Tennessee any time before May 20, 2020.
Estimated Amount: Varies - Proof of Purchase: N/A
- Case Name & Number: In re: Thalomid and Revlimid Antitrust Litigation, Case No. 14-6997 (MCA) (MAH), in the U.S. District Court for the District of New Jersey
(Click here to file a claim)
How To File a Claim
- Head over to the Cancer Medications Thalomid & Revlimid Claim Form.
- Look over the claim form to see if you are eligible.
- Complete the claim form with your information.
- Submit your claim by October 15, 2020 to receive your potential award!
Bottom Line
The settlement will benefit individuals who paid for cancer medications Thalomid or Revlimid in any eligible districts or states any time before May 20, 2020. You may be eligible for a potential award from the Cancer Medications Thalomid & Revlimid Class Action Lawsuit!
If you are eligible, file a claim by the deadline to receive your potential award! Don’t forget to take a look at our full list of Class Action Lawsuit Settlements!
The post Nasty Gal Text Message Class Action Lawsuit appeared first on Hustler Money Blog.